Gschwend P - Search Results

1

Feasibility, safety, and efficacy of injectable heroin prescription for refractory opioid addicts: a follow-up study.

Rehm J, Gschwend P, Steffen T, Gutzwiller F, Dobler-Mikola A, Uchtenhagen A. Rehm J, et al. Among authors: gschwend p. Lancet. 2001 Oct 27;358(9291):1417-23. doi: 10.1016/S0140-6736(01)06529-1. Lancet. 2001. PMID: 11705488

2

Mortality in heroin-assisted treatment in Switzerland 1994-2000.

Rehm J, Frick U, Hartwig C, Gutzwiller F, Gschwend P, Uchtenhagen A. Rehm J, et al. Among authors: gschwend p. Drug Alcohol Depend. 2005 Aug 1;79(2):137-43. doi: 10.1016/j.drugalcdep.2005.01.005. Epub 2005 Feb 26. Drug Alcohol Depend. 2005. PMID: 16002023

3

Prevalence of hepatitis and HIV infections and vaccination rates in patients entering the heroin-assisted treatment in Switzerland between 1994 and 2002.

Gerlich M, Gschwend P, Uchtenhagen A, Krämer A, Rehm J. Gerlich M, et al. Among authors: gschwend p. Eur J Epidemiol. 2006;21(7):545-9. doi: 10.1007/s10654-006-9023-z. Epub 2006 Jul 21. Eur J Epidemiol. 2006. PMID: 16858622

4

Complaints of heroin-maintained patients: A survey of symptoms ascribed to diacetylmorphine.

Dürsteler-MacFarland KM, Stohler R, Moldovanyi A, Rey S, Basdekis R, Gschwend P, Eschmann S, Rehm J. Dürsteler-MacFarland KM, et al. Among authors: gschwend p. Drug Alcohol Depend. 2006 Feb 28;81(3):231-9. doi: 10.1016/j.drugalcdep.2005.07.004. Epub 2005 Aug 30. Drug Alcohol Depend. 2006. PMID: 16135401

5

Dosage regimes in the prescription of heroin and other narcotics to chronic opioid addicts in Switzerland--Swiss national cohort study.

Gschwend P, Rehm J, Blättler R, Steffen T, Seidenberg A, Christen S, Bürki C, Gutzwiller F. Gschwend P, et al. Eur Addict Res. 2004;10(1):41-8. doi: 10.1159/000073725. Eur Addict Res. 2004. PMID: 14665805

6

Development of a monitoring system for heroin-assisted substitution treatment in Switzerland.

Gschwend P, Rehm J, Lezzi S, Blättler R, Steffen T, Gutzwiller F, Uchtenhagen A. Gschwend P, et al. Soz Praventivmed. 2002;47(1):33-8. doi: 10.1007/BF01318403. Soz Praventivmed. 2002. PMID: 12050928

7

Evaluating long-term effects of heroin-assisted treatment: the results of a 6-year follow-up.

Güttinger F, Gschwend P, Schulte B, Rehm J, Uchtenhagen A. Güttinger F, et al. Among authors: gschwend p. Eur Addict Res. 2003 Apr;9(2):73-9. doi: 10.1159/000068811. Eur Addict Res. 2003. PMID: 12644733

8

[Heroin-assisted treatment of opioid addicts in Switzerland from 1994-2001--utilisation and characteristics of admissions and discharges].

Gschwend P, Rehm J, Eschmann S, Uchtenhagen A. Gschwend P, et al. Gesundheitswesen. 2003 Feb;65(2):75-80. doi: 10.1055/s-2003-37696. Gesundheitswesen. 2003. PMID: 12632315 German.

9

[8 years experience with heroin-assited treatment in Switzerland--current results and future improvements].

Gschwend P, Eschmann S, Güttinger F, Hosek M, Rehm J, Uchtenhagen A. Gschwend P, et al. Ther Umsch. 2003 Jun;60(6):355-60. doi: 10.1024/0040-5930.60.6.355. Ther Umsch. 2003. PMID: 12848072 German.

10

What can the Swiss and Dutch trials tell us about the potential risks associated with heroin prescribing?

Bammer G, van den Brink W, Gschwend P, Hendriks V, Rehm J. Bammer G, et al. Among authors: gschwend p. Drug Alcohol Rev. 2003 Sep;22(3):363-71. doi: 10.1080/0959523031000154517. Drug Alcohol Rev. 2003. PMID: 15385231

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results